welcome
Reuters

Reuters

Health

Health

Next generation weight loss drugs aim to save muscle

Reuters
Summary
Nutrition label

80% Informative

The drugs are being tested to complement or replace the wildly popular Wegovy from Novo Nordisk and Eli Lilly's Zepbound .

Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures.

New England Consulting Group estimates the drugs could collectively bring in $1 billion to $5 billion a year by the end of the decade .

Scholar Rock is aiming for a change in lean body mass in the trial of its drug apitegromab.

Regeneron 's drug is also being tested alone and in combination with Wegovy .

The treatments must show that there is a structural change in the size of muscles or lean mass.

VR Score

91

Informative language

96

Neutral language

78

Article tone

formal

Language

English

Language complexity

55

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links